
ImmunXperts to increase capital and appoint Thibault Jonckheere as CEO
Gosselies, September 16th 2016 – ImmunXperts SA today announced that Thibault Jonckheere joined the fast growing company as CEO. Simultaneously, the immunogenicity company increased its capital to further accelerate the development of its immuno-oncology and cell therapy services. “ImmunXperts supports its partners in the evaluation of new drug candidates with a solid experimental platform for […]